TrialDiabetes, obesity & metabolism2017

Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes.

David Preiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.